Dr. Nagatomo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
16601 N 40th St
Ste 204
Phoenix, AZ 85032Phone+1 602-996-4747Fax+1 602-953-5466
Education & Training
- Main Line Health System/Lankenau Medical CenterResidency, Surgery, 2014 - 2019
- A. T. Still University Kirksville College of Osteopathic MedicineClass of 2013
Certifications & Licensure
- AZ State License 2022 - 2026
- PA State License 2013 - 2024
- LA State License 2020 - 2023
- American Board of Surgery Surgery
Publications & Presentations
PubMed
- 38 citationsHost IDO2 gene status influences tumor progression and radiotherapy response in KRAS-driven sporadic pancreatic cancersAvinoam Nevler, Alexander J. Muller, Erika Sutanto-Ward, James B. DuHadaway, Kei Nagatomo
Clinical Cancer Research. 2019-01-15 - 6 citationsHepatopancreatobiliary Fellowship Graduates: Where do They Stand today?:Terence Jackson, Joseph S. Lim, Edward E Cho, Houssam Osman, Kei Nagatomo
The American Surgeon. 2021-02-10 - 3 citationsOvercoming the Arduous Transition for Robotic Hepatopancreatobiliary Cases: A Multi-Procedure Learning Curve Study Utilizing CUSUM Analysis.Joseph S. Lim, Terence Jackson, James Kurtz, Edward E Cho, Shyam Vedantam
World Journal of Surgery. 2021-03-01
Press Mentions
- 68Ga-DOTATATE PET/CT Compared to Standard Imaging in Metastatic Neuroendocrine Tumors: A More Sensitive Test to Detect Liver Metastasis?March 4th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: